Clinical trial
Targeting IL-17A for Treatment-Resistant Depression
NCT04979910
Study timeline
Study start (actual)2021-08-27Date precision: day
Registry last updated2025-05-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
IxekizumabDRUG · verified · RxNorm: ixekizumab
Sponsors & collaborators
Icahn School of Medicine at Mount Sinailead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04979910 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.